Inventor
VEAL JAMES MARVIN
US93 patents
⚠️ This page may combine multiple inventors who share the name “VEAL JAMES MARVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CELGENE QUANTICEL RES INC
27 patentsUS11084793B2Aug 10, 2021
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC3 citations84
US10207999B2Feb 19, 2019
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC2 citations84
US10202381B2Feb 12, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US10112940B2Oct 30, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations84
US10023543B2Jul 17, 2018
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC4 citations84
US9776974B2Oct 3, 2017
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC4 citations84
US9771329B2Sep 26, 2017
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC6 citations84
US9725441B2Aug 8, 2017
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations84
US10316016B2Jun 11, 2019
Compositions comprising an inhibitor of lysine specific demethylase-1
CELGENE QUANTICEL RES INC4 citations83
US10047069B2Aug 14, 2018
Compositions comprising an inhibitor of lysine specific demethylase-1
CELGENE QUANTICEL RES INC4 citations83
US9828358B2Nov 28, 2017
Compositions comprising an inhibitor of lysine specific demethylase-1
CELGENE QUANTICEL RES INC5 citations83
US11535616B2Dec 27, 2022
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US11214542B2Jan 4, 2022
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10870634B2Dec 22, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10815234B2Oct 27, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US10807956B2Oct 20, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10654830B2May 19, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10654810B2May 19, 2020
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC2 citations73
US10611763B2Apr 7, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC2 citations73
US10597376B2Mar 24, 2020
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC1 citations73
US10597365B2Mar 24, 2020
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10494371B2Dec 3, 2019
Bromodomain inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10385051B2Aug 20, 2019
Inhibitors of lysine specific demethylase-1
CELGENE QUANTICEL RES INC2 citations73
US10208039B2Feb 19, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations73
US10179769B2Jan 15, 2019
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC1 citations73
US10030017B2Jul 24, 2018
Histone demethylase inhibitors
CELGENE QUANTICEL RES INC4 citations73
US9908885B2Mar 6, 2018
Bromodomain inhibitors
CELGENE QUANTICEL RES INC4 citations73
QUANTICEL PHARMACEUTICALS INC
10 patentsUS9255097B2Feb 9, 2016
Inhibitors of lysine specific demethylase-1
QUANTICEL PHARMACEUTICALS INC29 citations98
US8952151B2Feb 10, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC21 citations96
US9573930B2Feb 21, 2017
Inhibitors of lysine specific demethylase-1
QUANTICEL PHARMACEUTICALS INC15 citations93
US9447045B2Sep 20, 2016
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC20 citations93
US9085534B2Jul 21, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC8 citations93
US8987461B2Mar 24, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC13 citations91
US9676770B2Jun 13, 2017
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC5 citations84
US9643965B2May 9, 2017
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC6 citations84
US9133166B2Sep 15, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC10 citations84
US9107916B2Aug 18, 2015
Histone demethylase inhibitors
QUANTICEL PHARMACEUTICALS INC4 citations84
SMITHKLINE BEECHAM CORP
8 patentsUS6369086B1Apr 9, 2002
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP213 citations98
US7105529B2Sep 12, 2006
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects
SMITHKLINE BEECHAM CORP64 citations97
US7105530B2Sep 12, 2006
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP72 citations96
US6815439B2Nov 9, 2004
Substituted aza-oxindole derivatives
SMITHKLINE BEECHAM CORP53 citations96
US6541503B2Apr 1, 2003
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
SMITHKLINE BEECHAM CORP22 citations92
US7262203B2Aug 28, 2007
Pyrimidineamines as angiogenesis modulators
SMITHKLINE BEECHAM CORP32 citations90
US6624171B1Sep 23, 2003
Substituted aza-oxindole derivatives
SMITHKLINE BEECHAM CORP13 citations84
US7238813B2Jul 3, 2007
Chemical compounds
SMITHKLINE BEECHAM CORP20 citations81
GLAXO WELLCOME INC
2 patentsUS6268391B1Jul 31, 2001
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases
GLAXO WELLCOME INC238 citations96
US6387919B1May 14, 2002
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors
GLAXO WELLCOME INC34 citations90
Quanticel Pharmaceuticals
1 patentBOLOOR AMOGH
1 patentGLAXO GROUP LTD
1 patentShowing the top 50 of 93 patents by PatentIndex Score.